Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, November 14, 2023.
Just one week after winning FDA approval, Recor Medical reported the first commercial cases with its renal denervation treatment for hypertension. Fast Five hosts Sean Whooley and Jim Hammerand break down the details of the initial procedures and discuss how Recor got to this point.
Eko shared new clinical data demonstrating the real-world clinical efficacy of its AI-enabled Sensora platform. Hear about how the heart disease detection platform performed compared to a standard analog stethoscope.
Olympus initiated a voluntary field corrective action following reports of endobronchial combustion incidents involving bronchoscopes. The hosts discuss the ramifications of this issue and the instructions for users from the company.
Henry Schein’s third-quarter earnings report included updates on how the company is dealing with a major data breach. Listen to hear about the cyber breach and the potential impact it could have on the company’s financial performance in the future.
Within a month of announcing a restructuring plan and layoffs, ResMed has laid out its plans for a new operating model. The Fast Five hosts unpack the reasons behind these operational changes and break down some of the biggest executive changes that are coming as a result.
Follow the Fast Five hosts on LinkedIn
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
